CoChat

Current and Future Pharmacological Treatment Strategies in X‐Linked Adrenoleukodystrophy

Open access
Berger, Johannes, Pujol, Aurora, Aubourg, Patrick, Forss‐Petter, Sonja · 2010 · Brain Pathology
Cited by 90

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Mutations in the ABCD1 gene cause the clinical spectrum of the neurometabolic disorder X‐linked adrenoleukodystrophy/adrenomyeloneuropathy (X‐ALD/AMN). Currently, the most efficient therapeutic opportunity for patients with the cerebral form of X‐ALD is hematopoietic stem cell transplantation and possibly gene therapy of autologous hematopoietic stem cells. Both treatments, however, are only accessible to a subset of X‐ALD patients, mainly because of the lack of markers that can predict the onset of cerebral demyelination. Moreover, for female or male X‐ALD patients with AMN, currently only unsatisfying therapeutic opportunities are available. Thus, this review focuses on current and urgently needed future pharmacological therapies. The treatment of adrenal and gonadal insufficiency is well established, whereas applications of immunomodulatory and immunosuppressive drugs have failed to prevent progression of cerebral neuroinflammation. The use of Lorenzo's oil and the inefficacy of lovastatin to normalize very‐long‐chain fatty acids in clinical trials as well as currently experimental and therefore possible future therapeutic strategies are reviewed. The latter include pharmacological gene therapy mediated by targeted upregulation of ABCD2, the closest homolog of ABCD1, antioxidative drug treatment, small molecule histone deacetylase inhibitors such as butyrates and valproic acid, and other neuroprotective attempts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1750-3639.2010.00393.x

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 69

  1. 10.1016/S0014-5793(97)00122-1 · DOI · Paper page
  2. 10.1016/S0167-4781(00)00291-8 · DOI · Paper page
  3. 10.1046/j.1526-0968.2000.004005338.x · DOI
  4. 10.1016/j.bbamcr.2006.07.010 · DOI · Paper page
  5. 10.1016/j.freeradbiomed.2008.04.005 · DOI
  6. 10.1046/j.1471-4159.2001.00647.x · DOI · Paper page
  7. 10.1016/S0014-5793(00)01852-4 · DOI
  8. 10.1111/j.1750-3639.2010.00394.x · DOI · Paper page
  9. 10.1182/blood.V84.1.339.339 · DOI · Paper page
  10. 10.1212/WNL.58.6.901 · DOI · Paper page
  11. 10.1001/archneur.64.5.659 · DOI · Paper page
  12. 10.1056/NEJMc0907735 · DOI · Paper page
  13. 10.1016/j.nbd.2009.07.019 · DOI · Paper page
  14. 10.1016/S0014-5793(99)00379-8 · DOI · Paper page
  15. 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W · doi:10.1002/(sici)1097-4547(19971201)50:5<829::aid-jnr19>3.0.co;2-w
  16. 10.1124/mol.63.6.1296 · DOI
  17. 10.1093/hmg/ddq082 · DOI · Paper page
  18. 10.1016/j.neures.2009.05.002 · DOI · Paper page
  19. 10.1016/j.jsbmb.2009.04.006 · DOI
  20. 10.1083/jcb.200501036 · DOI · Paper page
  21. 10.1016/j.bbadis.2004.04.001 · DOI
  22. 10.1111/j.1471-4159.2006.03868.x · DOI · Paper page
  23. 10.1517/13543784.17.2.169 · DOI · Paper page
  24. 10.1016/j.yexcr.2008.10.031 · DOI
  25. 10.1038/nrd2681 · DOI · Paper page
  26. 10.1111/j.1471-4159.2008.05513.x · DOI · Paper page
  27. 10.1038/nn.2471 · DOI · Paper page
  28. 10.1073/pnas.97.2.817 · DOI · Paper page
  29. 10.1023/A:1005361607523 · DOI · Paper page
  30. Köhler W, 2005, Understanding and Treating Adrenoleukodystrophy. Present State and Future Perspectives, 28
  31. 10.1373/49.2.230 · DOI · Paper page
  32. 10.1016/j.taap.2007.09.014 · DOI
  33. 10.1128/MCB.22.23.8226-8240.2002 · DOI · Paper page
  34. 10.1074/jbc.274.46.32738 · DOI · Paper page
  35. 10.1111/j.1399-3046.2005.00447.x · DOI · Paper page
  36. 10.1002/ana.21677 · DOI
  37. 10.1067/mpd.2003.201 · DOI
  38. 10.1016/S0387-7604(89)80083-X · DOI
  39. 10.1038/nrc1779 · DOI · Paper page
  40. Moser HW, 2005, Understanding and Treating Adrenoleukodystrophy. Present State and Future Perspectives, 28
  41. Moser HW, 2001, The Metabolic and Molecular Bases of Inherited Disease, 3257
  42. 10.1212/01.WNL.0000079460.21925.D3 · DOI
  43. Murphy JV, 1982, Treatment of adrenoleukodystrophy by diet and plasmapheresis, Ann Neurol, 12, 220
  44. 10.1006/mgme.2000.2977 · DOI
  45. 10.1182/blood-2003-10-3402 · DOI · Paper page
  46. 10.1016/j.ejpn.2007.11.006 · DOI
  47. 10.1093/jnen/59.2.89 · DOI · Paper page
  48. 10.1097/01.jnen.0000190064.28559.a4 · DOI · Paper page
  49. 10.1006/geno.2000.6367 · DOI
  50. 10.1016/j.ymgme.2003.09.002 · DOI
  51. 10.1016/j.freeradbiomed.2007.06.019 · DOI · Paper page
  52. 10.1038/nrneurol.2009.26 · DOI · Paper page
  53. 10.1007/s10545-008-0841-x · DOI · Paper page
  54. 10.1016/S0014-5793(98)00370-6 · DOI · Paper page
  55. 10.1056/NEJM199809033391012 · DOI · Paper page
  56. 10.1023/A:1022535930009 · DOI · Paper page
  57. 10.1042/BJ20091798 · DOI
  58. 10.1074/jbc.M205079200 · DOI · Paper page
  59. 10.1016/S0171-9335(98)80121-0 · DOI · Paper page
  60. 10.1136/jnnp.67.3.290 · DOI · Paper page
  61. 10.1016/j.bbadis.2003.10.004 · DOI
  62. 10.1002/1531-8249(200004)47:4<552::AID-ANA28>3.0.CO;2-0 · DOI
  63. 10.1038/nrd3031 · DOI · Paper page
  64. 10.1093/hmg/11.22.2701 · DOI · Paper page
  65. 10.1016/j.febslet.2005.09.014 · DOI · Paper page
  66. 10.1074/jbc.M509450200 · DOI · Paper page
  67. 10.1016/j.ejcb.2008.08.002 · DOI
  68. 10.1023/A:1005634130286 · DOI · Paper page
  69. 10.1196/annals.1427.023 · DOI · Paper page

Cited by

See all 90

Metadata

Authors
Berger, J., Pujol, A., Aubourg, P., & Forss‐Petter, S.
Venue
Brain Pathology
Publisher
Wiley
Published
2010-06-07
Volume
20
Issue
4
Pages
845-856
ISSN
  • 1015-6305 (ISSN-L)
  • 1750-3639
OpenAlex
W2142167590
Cited by
90
References
45
FWCI
4.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current and Future Pharmacological Treatment Strategies in X‐Linked Adrenoleukodystrophy. https://app.cochat.ai/papers/10.1111/j.1750-3639.2010.00393.x
The paper
Berger, J., Pujol, A., Aubourg, P., & Forss‐Petter, S. (2010). Current and Future Pharmacological Treatment Strategies in X‐Linked Adrenoleukodystrophy. Brain Pathology. https://doi.org/10.1111/j.1750-3639.2010.00393.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.